DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,967,301 | +104187.0% | 24,052 | +0.9% | 0.46% | +8.4% |
| Q2 2023 | $5,722 | -2.7% | 23,840 | +2.2% | 0.43% | -11.0% |
| Q1 2023 | $5,878 | -5.6% | 23,323 | -0.6% | 0.48% | -10.7% |
| Q4 2022 | $6,227 | -99.9% | 23,462 | 0.0% | 0.54% | -3.9% |
| Q3 2022 | $6,060,000 | +8.1% | 23,462 | +6.1% | 0.56% | +9.1% |
| Q2 2022 | $5,605,000 | +1.7% | 22,108 | +17.7% | 0.52% | +5.5% |
| Q1 2022 | $5,510,000 | +1.3% | 18,783 | +13.7% | 0.49% | -3.6% |
| Q4 2021 | $5,437,000 | +8.2% | 16,524 | +0.1% | 0.51% | -4.5% |
| Q3 2021 | $5,027,000 | +13.4% | 16,512 | -0.1% | 0.53% | +12.8% |
| Q2 2021 | $4,434,000 | +14.9% | 16,523 | -3.7% | 0.47% | +13.8% |
| Q1 2021 | $3,860,000 | -3.1% | 17,151 | -4.4% | 0.41% | -8.6% |
| Q4 2020 | $3,985,000 | +11.7% | 17,938 | +8.3% | 0.45% | -8.7% |
| Q3 2020 | $3,567,000 | +30.3% | 16,563 | +7.0% | 0.50% | +12.2% |
| Q2 2020 | $2,737,000 | +2.1% | 15,476 | -20.1% | 0.44% | +5.5% |
| Q1 2020 | $2,682,000 | +15.4% | 19,378 | +28.0% | 0.42% | +12.4% |
| Q4 2019 | $2,324,000 | +6.8% | 15,142 | +0.5% | 0.37% | -2.4% |
| Q3 2019 | $2,176,000 | +15.9% | 15,063 | +14.6% | 0.38% | +0.8% |
| Q2 2019 | $1,878,000 | +13.9% | 13,139 | +5.2% | 0.38% | +4.7% |
| Q1 2019 | $1,649,000 | +31.1% | 12,492 | +2.4% | 0.36% | +14.6% |
| Q4 2018 | $1,258,000 | -0.5% | 12,201 | +4.9% | 0.32% | +12.5% |
| Q3 2018 | $1,264,000 | +10.6% | 11,632 | +0.5% | 0.28% | +2.6% |
| Q2 2018 | $1,143,000 | -16.9% | 11,578 | -17.6% | 0.27% | +0.7% |
| Q1 2018 | $1,376,000 | -8.8% | 14,053 | -13.6% | 0.27% | +7.5% |
| Q4 2017 | $1,509,000 | +8.9% | 16,256 | +0.6% | 0.25% | +2.9% |
| Q3 2017 | $1,386,000 | -1.8% | 16,152 | -3.4% | 0.24% | -2.4% |
| Q2 2017 | $1,412,000 | +0.1% | 16,729 | +1.4% | 0.25% | -3.8% |
| Q1 2017 | $1,411,000 | -8.0% | 16,497 | -16.3% | 0.26% | +5.2% |
| Q4 2016 | $1,534,000 | -12.4% | 19,707 | -11.8% | 0.25% | -10.5% |
| Q3 2016 | $1,752,000 | -28.3% | 22,346 | -7.6% | 0.28% | -17.1% |
| Q2 2016 | $2,443,000 | -4.8% | 24,192 | -10.6% | 0.33% | +5.4% |
| Q1 2016 | $2,566,000 | +23.7% | 27,052 | +21.1% | 0.32% | +1.6% |
| Q4 2015 | $2,074,000 | +22.5% | 22,331 | +12.4% | 0.31% | +3.0% |
| Q3 2015 | $1,693,000 | -1.5% | 19,868 | -1.1% | 0.30% | +3.8% |
| Q2 2015 | $1,719,000 | +2.6% | 20,088 | +1.8% | 0.29% | +1.7% |
| Q1 2015 | $1,676,000 | -10.0% | 19,741 | -9.1% | 0.29% | -0.7% |
| Q4 2014 | $1,862,000 | +13.6% | 21,724 | +2.3% | 0.29% | +2.1% |
| Q3 2014 | $1,639,000 | -1.7% | 21,233 | +0.2% | 0.28% | +3.3% |
| Q2 2014 | $1,668,000 | +7.4% | 21,183 | +2.3% | 0.27% | +0.4% |
| Q1 2014 | $1,553,000 | -5.2% | 20,710 | -2.5% | 0.27% | -3.5% |
| Q4 2013 | $1,639,000 | +11.0% | 21,233 | -0.4% | 0.28% | +0.4% |
| Q3 2013 | $1,477,000 | – | 21,312 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |